What causes shortness of breath and difficulty breathing after mycoplasma pneumonia, and what should be done about it?
Sep 27, 2023
Source: Cainiu Health
Dr. Yang Ziqi
Introduction
Under normal circumstances, shortness of breath or difficulty breathing after Mycoplasma pneumonia may be caused by various factors such as post-recovery sequelae, airway obstruction due to thrombosis, pleurisy, bronchitis, or pulmonary hypertension. Patients should promptly seek medical attention at a正规 hospital and receive treatment according to the doctor's recommendations. In summary, shortness of breath after Mycoplasma pneumonia may result from multiple causes.
Under normal circumstances, shortness of breath or difficulty breathing after Mycoplasma pneumonia may be caused by post-recovery sequelae, airway blockage due to thrombosis, pleurisy, bronchitis, pulmonary hypertension, and other reasons. Patients should seek timely medical evaluation at a正规 hospital and receive treatment as advised by a physician. Specific causes are as follows:
1. Post-recovery sequelae
Most individuals can fully recover after Mycoplasma pneumonia; however, if the infection is not properly or completely treated, persistent shortness of breath or difficulty breathing may occur. Medications such as ambroxol hydrochloride syrup, azithromycin dispersible tablets, and clarithromycin capsules may be used under medical guidance.
2. Airway obstruction due to thrombosis
Patients with Mycoplasma pneumonia may experience dyspnea due to intense inflammatory responses in the airways. Thrombotic blockage of the airways could also lead to shortness of breath. Treatment under medical supervision may include theophylline sustained-release tablets, doxofylline tablets, and atorvastatin calcium tablets.
3. Pleurisy
If a patient develops pleurisy, Mycoplasma pneumonia may trigger inflammation of the pleura—the membrane surrounding the lungs—leading to shortness of breath. Treatment options under medical advice may include ambroxol hydrochloride syrup, Qingfei Bayeshiwan pills, and penicillin V potassium tablets.
4. Bronchitis
If a patient has bronchitis, Mycoplasma pneumonia may exacerbate or trigger bronchial inflammation, damaging the bronchi and causing shortness of breath, thereby increasing the risk of respiratory distress. As directed by a physician, medications such as salbutamol sulfate tablets, budesonide inhalation aerosol, and Qiangli Pipa Lu (Powerful Loquat Syrup) may be used.
5. Pulmonary hypertension
Mycoplasma pneumonia may cause inflammation of the pulmonary blood vessels, leading to pulmonary hypertension. This condition narrows the pulmonary arteries, forcing the heart to work harder to pump blood, resulting in shortness of breath. Under medical supervision, patients may be treated with nifedipine tablets, deslanoside injection, or dopamine hydrochloride injection.
In summary, shortness of breath after Mycoplasma pneumonia may stem from various causes. If symptoms progressively worsen, prompt medical attention is recommended to prevent disease progression.
